NeuroVive Pharmaceutical AB Ingresos Q/Q
¿Qué es el Ingresos Q/Q de NeuroVive Pharmaceutical AB?
El Ingresos Q/Q de NeuroVive Pharmaceutical AB es -63.53%
¿Cuál es la definición de Ingresos Q/Q?
El crecimiento de los ingresos trimestrales, año tras año, es el aumento de los ingresos de una empresa en comparación con el compiortamiento en el trimestre correspondiente de un año anterior expresado como un porcentaje.
Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.
Ingresos Q/Q de compañías en Sector Health Care en OTC en comparadas con NeuroVive Pharmaceutical AB
¿Qué hace NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Empresas con ingresos q/q similar a NeuroVive Pharmaceutical AB
- XXL tiene Ingresos Q/Q de -63.64%
- Mosaic Brands tiene Ingresos Q/Q de -63.63%
- Sundance tiene Ingresos Q/Q de -63.61%
- Urban&Civic plc tiene Ingresos Q/Q de -63.56%
- Pioneer Embroideries tiene Ingresos Q/Q de -63.55%
- u-blox AG tiene Ingresos Q/Q de -63.54%
- NeuroVive Pharmaceutical AB tiene Ingresos Q/Q de -63.53%
- Remsons Industries tiene Ingresos Q/Q de -63.52%
- AYM Syntex tiene Ingresos Q/Q de -63.44%
- Conscience Capital tiene Ingresos Q/Q de -63.39%
- Jolimark tiene Ingresos Q/Q de -63.36%
- Cntrl China New Life Ltd tiene Ingresos Q/Q de -63.36%
- Larry Jewelry International tiene Ingresos Q/Q de -63.35%